Home
Emcure Pharmaceuticals Ltd Board of Directors
Board of Directors at Emcure Pharmaceuticals Ltd
Chairman & Independent Directo
Company Sec. & Compli. Officer
Whole Time Director
Whole Time Director
Independent Director
Key Highlights
- MUKUND KESHAO GURJAR continues to serve as the Whole Time Director in 2024, maintaining the same position as in the previous year.
- SUNIL RAJNIKANT MEHTA continues to serve as the Whole Time Director in 2024, maintaining the same position as in the previous year.
- SATISH RAMANLAL MEHTA continues to serve as the Managing Director & CEO in 2024, maintaining the same position as in the previous year.
- Berjis M Desai continues to serve as the Chairman & Independent Directo in 2024, maintaining the same position as in the previous year.
- NAMITA VIKAS THAPAR continues to serve as the Whole Time Director in 2024, maintaining the same position as in the previous year.

Emcure Pharmaceuticals Ltd
NSE: EMCURE
Share Price
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 996.75 |
20 Feb 2025 | 991.6 |
19 Feb 2025 | 996 |
18 Feb 2025 | 987.9 |
17 Feb 2025 | 959.45 |
14 Feb 2025 | 994.5 |
13 Feb 2025 | 1062.8 |
12 Feb 2025 | 1073.75 |
11 Feb 2025 | 1102.2 |
10 Feb 2025 | 1172.5 |
Company Fundamentals for Emcure Pharmaceuticals Ltd
Market Cap
18,881 Cr
EPS
32.1
P/E Ratio (TTM)
31.1
P/B Ratio (TTM)
4.6
Day’s High
1009.25
Day’s Low
980.1
DTE
0.3
ROE
13.8
52 Week High
1577.5
52 Week Low
942.45
ROCE
18.7
Market Price of Emcure Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Emcure Pharmaceuticals Ltd News Hub
Emcure Pharmaceuticals receives upgrade in credit ratings from CRISIL
Emcure Pharmaceuticals has received upgrade in credit ratings from CRISIL for bank facilities of Rs
Read more
13 Aug 24
Emcure Pharmaceuticals receives upgrade in credit ratings for bank facilities
Emcure Pharmaceuticals announced that CARE Ratings has upgraded the credit ratings assigned to bank
Read more
13 Aug 24
Emcure Pharmaceuticals consolidated net profit rises 10.48% in the June 2024 quarter
Net profit of Emcure Pharmaceuticals rose 10.48% to Rs 144.08 crore in the quarter ended June 2024 a
Read more
14 Aug 24
Emcure Pharmaceuticals to declare Quarterly Result
Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 202
Read more
10 Aug 24